No Detectable Resistance to Tenofovir Disoproxil Fumarate (TDF) in HBeAg+ and HBeAg- Patients With Chronic Hepatitis B (CHB) After Eight Years of Treatment
Reported by Jules Levin
APASL 2015
March 12-15, Istanbul, Turkey
Amoreena Corsa,1 Yang Liu,1 John Flaherty,1 Patrick Marcellin,2 Michael Miller,1 Kathryn M. Kitrinos1
1Gilead Sciences, Inc., Foster City, California, USA; 2Hopital Beaujon, University of Paris, Clichy, France
